Prot #CY 6032: A Phase 3, Multi‐Center, Randomized, Double‐Blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Project: Research project

Project Details

StatusActive
Effective start/end date8/3/23 → 8/3/26

Funding

  • Fortrea, Inc. (Prot #CY 6032 // Prot #CY 6032)
  • Cytokinetics, Inc. (Prot #CY 6032 // Prot #CY 6032)